883 related articles for article (PubMed ID: 16443173)
21. Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone.
Wargent E; Stocker C; Augstein P; Heinke P; Meyer A; Hoffmann T; Subramanian A; Sennitt MV; Demuth HU; Arch JR; Cawthorne MA
Diabetes Obes Metab; 2005 Mar; 7(2):170-81. PubMed ID: 15715890
[TBL] [Abstract][Full Text] [Related]
22. Reduced expression of the KATP channel subunit, Kir6.2, is associated with decreased expression of neuropeptide Y and agouti-related protein in the hypothalami of Zucker diabetic fatty rats.
Gyte A; Pritchard LE; Jones HB; Brennand JC; White A
J Neuroendocrinol; 2007 Dec; 19(12):941-51. PubMed ID: 18001323
[TBL] [Abstract][Full Text] [Related]
23. Tissue-specific alterations of methyl group metabolism with DNA hypermethylation in the Zucker (type 2) diabetic fatty rat.
Williams KT; Schalinske KL
Diabetes Metab Res Rev; 2012 Feb; 28(2):123-31. PubMed ID: 21818837
[TBL] [Abstract][Full Text] [Related]
24. Analysis of gene expression profiles in insulin-sensitive tissues from pre-diabetic and diabetic Zucker diabetic fatty rats.
Suh YH; Kim Y; Bang JH; Choi KS; Lee JW; Kim WH; Oh TJ; An S; Jung MH
J Mol Endocrinol; 2005 Apr; 34(2):299-315. PubMed ID: 15821098
[TBL] [Abstract][Full Text] [Related]
25. Adiponectin receptors: expression in Zucker diabetic rats and effects of fenofibrate and metformin.
Metais C; Forcheron F; Abdallah P; Basset A; Del Carmine P; Bricca G; Beylot M
Metabolism; 2008 Jul; 57(7):946-53. PubMed ID: 18555836
[TBL] [Abstract][Full Text] [Related]
26. Voluntary running exercise prevents β-cell failure in susceptible islets of the Zucker diabetic fatty rat.
Delghingaro-Augusto V; Décary S; Peyot ML; Latour MG; Lamontagne J; Paradis-Isler N; Lacharité-Lemieux M; Akakpo H; Birot O; Nolan CJ; Prentki M; Bergeron R
Am J Physiol Endocrinol Metab; 2012 Jan; 302(2):E254-64. PubMed ID: 22045312
[TBL] [Abstract][Full Text] [Related]
27. Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats.
Oltman CL; Coppey LJ; Gellett JS; Davidson EP; Lund DD; Yorek MA
Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E113-22. PubMed ID: 15727946
[TBL] [Abstract][Full Text] [Related]
28. Lack of in vivo effect of vanadium on GLUT4 translocation in white adipose tissue of streptozotocin-diabetic rats.
Cam MC; Brownsey RW; Rodrigues B; McNeill JH
Metabolism; 2001 Jun; 50(6):674-80. PubMed ID: 11398144
[TBL] [Abstract][Full Text] [Related]
29. Glucose-lowering effects of a new organic vanadium complex, bis(maltolato)oxovanadium(IV).
Yuen VG; Orvig C; McNeill JH
Can J Physiol Pharmacol; 1993; 71(3-4):263-9. PubMed ID: 8402390
[TBL] [Abstract][Full Text] [Related]
30. In vivo effects of insulin and bis(maltolato)oxovanadium (IV) on PKB activity in the skeletal muscle and liver of diabetic rats.
Marzban L; Bhanot S; McNeill JH
Mol Cell Biochem; 2001 Jul; 223(1-2):147-57. PubMed ID: 11681716
[TBL] [Abstract][Full Text] [Related]
31. Recurrent intermittent restraint delays fed and fasting hyperglycemia and improves glucose return to baseline levels during glucose tolerance tests in the Zucker diabetic fatty rat--role of food intake and corticosterone.
Bates HE; Kiraly MA; Yue JT; Goche Montes D; Elliott ME; Riddell MC; Matthews SG; Vranic M
Metabolism; 2007 Aug; 56(8):1065-75. PubMed ID: 17618951
[TBL] [Abstract][Full Text] [Related]
32. Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes.
Reed MJ; Meszaros K; Entes LJ; Claypool MD; Pinkett JG; Brignetti D; Luo J; Khandwala A; Reaven GM
Diabetologia; 1999 Jan; 42(1):102-6. PubMed ID: 10027587
[TBL] [Abstract][Full Text] [Related]
33. Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats.
Niu Y; Liu W; Tian C; Xie M; Gao L; Chen Z; Chen X; Li L
Eur J Pharmacol; 2007 Oct; 572(2-3):213-9. PubMed ID: 17651728
[TBL] [Abstract][Full Text] [Related]
34. Changes in pancreatic islet glucokinase and hexokinase activities with increasing age, obesity, and the onset of diabetes.
Cockburn BN; Ostrega DM; Sturis J; Kubstrup C; Polonsky KS; Bell GI
Diabetes; 1997 Sep; 46(9):1434-9. PubMed ID: 9287043
[TBL] [Abstract][Full Text] [Related]
35. Comparison of tissue metal concentrations in Zucker lean, Zucker obese, and Zucker diabetic fatty rats and the effects of chromium supplementation on tissue metal concentrations.
Staniek H; Rhodes NR; Di Bona KR; Deng G; Love ST; Pledger LA; Blount J; Gomberg E; Grappe F; Cernosek C; Peoples B; Rasco JF; Krejpcio Z; Vincent JB
Biol Trace Elem Res; 2013 Mar; 151(3):373-83. PubMed ID: 23250541
[TBL] [Abstract][Full Text] [Related]
36. Melatonin improves glucose homeostasis in young Zucker diabetic fatty rats.
Agil A; Rosado I; Ruiz R; Figueroa A; Zen N; Fernández-Vázquez G
J Pineal Res; 2012 Mar; 52(2):203-10. PubMed ID: 21883445
[TBL] [Abstract][Full Text] [Related]
37. Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate.
Forcheron F; Abdallah P; Basset A; del Carmine P; Haffar G; Beylot M
Obesity (Silver Spring); 2009 Jul; 17(7):1381-9. PubMed ID: 19553925
[TBL] [Abstract][Full Text] [Related]
38. Postprandial insulin resistance in Zucker diabetic fatty rats is associated with parasympathetic-nitric oxide axis deficiencies.
Afonso RA; Fernandes AB; Santos C; Ligeiro D; Ribeiro RT; Lima IS; Patarrao RS; Videira PA; Caldeira J; Macedo MP
J Neuroendocrinol; 2012 Oct; 24(10):1346-55. PubMed ID: 22672343
[TBL] [Abstract][Full Text] [Related]
39. Vanadium: Risks and possible benefits in the light of a comprehensive overview of its pharmacotoxicological mechanisms and multi-applications with a summary of further research trends.
Ścibior A; Pietrzyk Ł; Plewa Z; Skiba A
J Trace Elem Med Biol; 2020 Sep; 61():126508. PubMed ID: 32305626
[TBL] [Abstract][Full Text] [Related]
40. Effects of three and eight weeks oral administration of bis(maltolato)oxovanadium(IV) on plasma homocysteine and cysteine levels in streptozotocin-induced diabetic rats.
Wasan KM; Risovic V; Yuen VG; Hicke A; McNeill JH
Exp Clin Cardiol; 2004; 9(2):125-9. PubMed ID: 19641699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
